Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-001658
Filing Date
2016-08-16
Accepted
2016-08-16 14:13:21
Documents
39
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 528066
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF sbfm_ex311.htm EX-31.1 13005
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF sbfm_ex312.htm EX-31.2 12693
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE sbfm_ex32.htm EX-32 6991
5 IMAGE sbfm_10q000.jpg GRAPHIC 35330
6 IMAGE sbfm_10q001.jpg GRAPHIC 12553
  Complete submission text file 0001654954-16-001658.txt   1485873

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sbfm-20160630.xml EX-101.INS 88396
8 XBRL TAXONOMY EXTENSION SCHEMA sbfm-20160630.xsd EX-101.SCH 16556
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbfm-20160630_cal.xml EX-101.CAL 33033
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbfm-20160630_def.xml EX-101.DEF 17616
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbfm-20160630_lab.xml EX-101.LAB 110476
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbfm-20160630_pre.xml EX-101.PRE 81796
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 161835641
SIC: 8731 Services-Commercial Physical & Biological Research